Log In
BCIQ
Print this Print this
 

Lipid Profile ALT

  Manage Alerts
Collapse Summary General Information
Company Alere Inc.
DescriptionTest panel combining an alanine aminotransferase (ALT) test with a lipid profile
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationMetabolic, Diagnostic
Indication DetailsMeasure total, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, triglyceride and alanine aminotransferase (ALT)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$8,400.0M

$5,800.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/01/2016

$8,400.0M

$5,800.0M

0

Get a free BioCentury trial today